AdventHealth Central and East Florida Media Resources
Have an account question? Check out our help center.
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
Choose the health content that’s right for you, and get it delivered right in your inbox.
.
.As part of our ongoing Facebook Live series, the AdventHealth Morning Briefing, physicians with the AdventHealth Transplant Institute talked about COVID-19’s impact on organ transplants.
Dear news desks and reporters: Please see the following updates from AdventHealth for May 1, 2020:
Media advisory
AdventHealth’s Translational Research Institute is participating in the nationwide MoTrPAC study, which will try to determine why exercise is good for us on the molecular level.
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.